Mirion Technologies Inc

Mirion Technologies designs, manufactures, and services radiation detection, measurement, and monitoring systems for nuclear power plants, medical isotope production, defense, and research facilities. Its portfolio includes handheld detectors, fixed-plant monitors, dosimeters, and imaging cameras critical for radiation safety, contamination control, and compliance. Amid the nuclear renaissance fueled by SMR development and reactor life extensions, Mirion holds a strategic position by supplying indispensable tools for operational safety and efficiency, supporting the global push for reliable baseload clean energy.

In the last 12 months, Mirion posted Q1 2024 revenue of $198.6 million, up 8% year-over-year with 5% organic growth, driven by Medical and Nuclear segments; it acquired High Technology Sources in December 2023 to expand gamma irradiation capabilities and secured contracts for SMR instrumentation prototypes. Key risks include delays in nuclear project approvals amid regulatory scrutiny, vulnerability to supply chain bottlenecks for rare-earth components, and margin pressure from competition by Thermo Fisher and Canberra, alongside cyclical demand tied to government budgets.

AI-generated brief · refreshed 2 days ago